UK Public Sector Contracts & Tenders

The contract will initially be delivered for NHS-funded care in England and Wales for a period of 3 years, at an initial maximum total budget of up to £1,523,232 GBP including VAT (a total budget of up to £1,269,360 GBP excluding VAT). Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years at a potential value of £507,744 GBP per year including VAT, £423,120 GBP per year excluding VAT. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £1,523,232 GBP including VAT, £1,269,360 GBP excluding VAT. The maximum budget ‘core’ value excludes the potential two year extension and aspirational intent as described in section 14.4 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £9,231,961 GBP including VAT. There is also a potential that the contract price will be subject to discretionary inflationary uplift. The role of a national clinical audit is to stimulate healthcare improvement through the provision of timely and high quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. The overarching aim of this audit is to stimulate improvements in care that NHS Mental Health Trusts in England and Health Boards in Wales provide to people with psychosis by measuring and reporting variations in quality of care and patient outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit so far, and enhance the ability for the audit to be used for healthcare improvement. To do this, the supplier will need to engage with clinicians, patients and commissioners (both local and national) and regional networks. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and where there is a shared understanding of what good care looks like. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly, and appropriate tools, support and guidance accompany the data outputs. The intent is for all of these features to be implemented and improved during the period of this future contract. The audit will continue to promote equitable, high-quality, evidence-based care for all NHS-funded patients receiving support from Early Intervention in Psychosis (EIP) services. There is no planned significant changes to the existing core project model, with an ongoing emphasis on strengthening quality, relevance, and programme resilience. The audit will prioritise the use of routinely collected data and explore supplementary, non-duplicative data sources, including data linkage, to enhance health outcomes information. There also needs to be a continued focus on improving Systemized Nomenclature of Medicine – Clinical Terms (SNOMED) coding guidance for EIP and data quality. The anticipated outputs are: 1.Near real-time dynamic and interactive metric results 2.Publication of an annual state of the nation report 3.Infographic based on the annual state of the nation report 4.Quality improvement resources 5.The identification and notification of outliers 6.One-off organisational audit report The programme must remain effective and responsive to changing delivery service models, including for example emerging neighbourhood-based integrated models, including the context of third-sector delivery. The scope of this national clinical audit programme comprises a prospective audit of key measures on the processes and outcomes of care provided by Early Intervention in Psychosis (EIP) teams to people with psychosis in England and Wales. As with all our contracts, HQIP prioritises the minimisation of local data entry/submission burden and the impact of data flows on patient privacy, and the maximisation of quality, timeliness and cost-efficiency of reporting of data. To avoid burden on the healthcare system, the audit will use electronic patient record data and/or routine data (e.g. hospital episode statistics (HES) and Mental Health Services Data Set (MHSDS)) whenever available, rather than collect bespoke data. Where data items are collected from providers/services, these must be directly aligned with the audit quality improvement intent in order to minimise collection burden. Further details of the existing audit can be found at: https://www.rcpsych.ac.uk/improving-care/ccqi/national-clinical-audits/national-clinical-audit-of-psychosis For more information about this opportunity, please visit the eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./27PA5X5394 To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/27PA5X5394

The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification). The maximum budget ‘core’ value of £930,380.40 GBP including VAT and £775,317.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent which will be included in the service specification at point of tender, meaning the ceiling value has the potential to be higher. Due to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a two-year pro rata of the core three- year funding, estimated at £516,878.00 excluding VAT. This proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year. Further to this funding, the final specification will contain a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, excluding the potential two- year extension, is unknown at point of drafting this notice, so, an estimated value of £7,000,000 excluding VAT is applied to form the maximum ceiling value AT POINT OF DRAFTING THIS NOTICE. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures that will be listed in the final specification. The role of a national clinical audit is to stimulate healthcare improvement and reduce unwarranted variation through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data can also improve the system, and there is a shared understanding of what good care looks like. The National Early Inflammatory Autoimmune Diseases Audit, previously the National Early Inflammatory Arthritis Audit (NEIAA) was established in 2013 and since 2017 has been delivered by the British Society for Rheumatology (BSR) - https://www.rheumatology.org.uk/ The overarching aim is to stimulate improvements in care for patients by measuring variations in quality, experience and outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly and appropriate tools, support and guidance accompany the data outputs. The intent is for all these features of the audit to be implemented and improved during the period of this contract. The NEIAA should conform to the overarching aims and objective of all NCAPOP audits National clinical audits are expected to: a.Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement b.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate c.Enable improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting d.Engage service users, patients, parents, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit e.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract f.Ensure robust methodological and statistical input at all stages of the audit g.Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly h.Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data i.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget j.Develop and maintain strong engagement with local clinicians, networks, commissioners, parents and their families and carers and charity and community support groups in order to drive improvements in services. and in addition, the specific three -year data driven healthcare quality improvement aims are: 1.Increase the proportion of people with immune-mediated inflammatory diseases (IMID) referred to rheumatology services within three working days 2.For people with IMID reduce the delay in first rheumatology appointment, aiming to increase the proportion of patients seeing a rheumatologist within three weeks 3.Shorten the time from referral to starting treatment for IMID, increasing the proportion of patients starting treatment within six weeks of referral 4.Increase the proportion of patients receiving a holistic annual review 5.Reduce diagnostic delay for patients with rare IMID 6.Reduce diagnostic delay for patients with Axial Spondyloarthritis 7.Reduce data collection burden for local clinical teams The audit supplier will work with commissioners and funders to create a coherent strategy for how the improvement goals listed above, or similar, will support organisations in the rheumatology pathway to try and achieve them. See section 4 for further information on healthcare quality improvement. Further details of the existing audit can be found at: https://www.rheumatology.org.uk/improving-care/audits/neiaa For more information about this opportunity, please visit the eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./G355Y3Y9WC To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/G355Y3Y9WC